MedTrace Logo

Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients

NCT04456855 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 358

Last updated 2020-07-07

No results posted yet for this study

Summary

Current guidelines lack definitive evidences about the relative benefits of locoregional surgery for the primary tumor in de novo stage IV breast cancer. The aim of this study (SYSBTC-001) was to investigate the role of locoregional surgery for primary tumor in de novo stage IV breast cancer.

Conditions

Interventions

PROCEDURE

Locoregional surgery

Patients had pathologically confirmed operable stage IV breast infiltrating carcinoma at initial presentation, and had locoregional surgery for the breast cancer.

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • First People's Hospital of Foshan

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Herui Yao, PhD · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  • Jun Tang, PhD · Sun Yat-sen University

  • Guolin Ye, PhD · First People's Hospital of Foshan

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-10-30
Completion
2021-07-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456855 on ClinicalTrials.gov